The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation
Clinical trial NCT05769738 · UNKNOWN
Trial details
- NCT number
- NCT05769738
- Sponsor
- American University of Beirut Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.